Isturisa

Medicinal product

(Invented) name

Isturisa

Active substance (s)

Osilodrostatas

Strength

5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

H02CA02, osilodrostat

Marketing authorisation holder

Recordati Rare Diseases, Prancūzija

Date of authorisation

2020-01-14

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Osilodrostatas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
103090	89191	1089191	lizdinė plokštelė	N60		Receptinis	EU/1/19/1407/002	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-01-14	Registruotas